U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07857343) titled 'CardioFlow Transcatheter Mitral Valve Replacement System Pre-market Clinical Investigation' on Sept. 21.
Brief Summary: This is a prospective, multi-center, single-arm study to assess the safety and effectiveness of Microport CardioFlow Transcatheter Mitral Valve Replacement system in the treatment of moderate to severe or severe degenerative mitral regurgitation and to provide the clinical evidence for product registration in China or other countries
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Degenerative Mitral Regurgitation
Intervention:
DEVICE: Microport CardioFlow Mitral Valve Replacement System
Patie...